🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wayne Woo

Novavax (United States)

ORCID: 0000-0002-4272-4264
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults”.

Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults

The Journals of Gerontology Series A(2020)10.1093/gerona/glaa127
N/A
0DataRank · unranked
18 citations

Myron J. Levin, Michael Chen, Sean Matthews, Megan Riley, Wayne Woo +6 more

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

medRxiv(2021)10.1101/2021.10.05.21264567
N/A
0DataRank · unranked
37 citations

Karen L. Kotloff, Cynthia L. Gay, Germán Áñez, Jeffrey Adelglass, Alejandro Quintín Barrat Hernández +29 more

Immune Correlates Analysis of the PREVENT-19 COVID-19 Vaccine Efficacy Clinical Trial

medRxiv(2022)10.1101/2022.06.22.22276362
N/A
0DataRank · unranked
15 citations

Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo +35 more

Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

Nature Communications(2023)10.1038/s41467-022-35768-3
N/A
0DataRank · unranked
102 citations

Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo +35 more

Immunogenicity of NVX-CoV2373 in PREVENT-19: A Phase 3, Randomized, Placebo-Controlled Trial in Adults in the United States and Mexico

medRxiv(2023)10.1101/2023.05.08.23289670
N/A
0DataRank · unranked
1 citations

Karen L. Kotloff, Cynthia L. Gay, J C Nelson, Haoua Dunbar, Shane Cloney-Clark +7 more

Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine

Clinical Infectious Diseases(2024)10.1093/cid/ciae081
N/A
0DataRank · unranked
10 citations

Allyson Mateja, Michael P. Fay, Craig A. Magaret, Yunda Huang, Youyi Fong +8 more

Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: a phase 3, randomized, placebo-controlled trial (PREVENT-19)

medRxiv(2024)10.1101/2024.11.07.24316930
N/A
0DataRank · unranked
0 citations

Alice McGarry, Wayne Woo, Karen L. Kotloff, Cynthia L. Gay, Mingzhu Zhu +14 more

Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19)

Vaccine(2025)10.1016/j.vaccine.2025.127362
N/A
0DataRank · unranked
3 citations

Alice McGarry, Wayne Woo, Karen L. Kotloff, Cynthia L. Gay, Mingzhu Zhu +15 more

Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine

Clinical Infectious Diseases(2025)10.1093/cid/ciaf558
N/A
0DataRank · unranked
1 citations

Yunda Huang, Ying Huang, Wayne Woo, Alice McGarry, Germán Áñez +37 more